牙周病诊断与风险评估的微生物标志物:系统文献检索与叙述性综合
本系统文献检索纳入31项研究,多为横断面或病例对照设计,评估微生物生物标志物在区分健康与疾病、预测疾病进展及评估治疗结果方面的准确性。研究发现,基于复合微生物组的指标如龈下微生物失调指数达到最高诊断准确性(AUC > 0.95),但方法学异质性和标准不一致限制了可靠性。结论认为当前证据尚不足以用于临床实施。
要点
- 微生物标志物在牙周病诊断中有前景,但当前证据不足以临床实施。
- 最高诊断准确性(AUC > 0.95)见于龈下微生物失调指数等复合微生物组指标。
- 方法学异质性和诊断标准不一致限制了可靠性,未来需标准化方法。
核心结论
- 微生物生物标志物在牙周病诊断和监测中有前景,但当前证据不足以用于临床实施。
研究设计与样本
- PRISMA指导的检索涵盖MEDLINE、EMBAS和WEB OF SCIENCE,纳入每组至少20名参与者的横断面和纵向研究(如随机对照试验、队列研究)。
- 纳入研究基于明确临床标准诊断牙周健康、牙龈炎或牙周炎,并采用口腔液体和/或牙菌斑的微生物学分析。
- 诊断准确性需通过敏感性、特异性或受试者工作特征曲线下面积(AUC)评估,或提供可计算这些指标的数据。
- 共纳入31项研究,大多为横断面或病例对照设计。
主要发现
- 采样部位、微生物学分析和诊断定义存在显著变异性,使直接比较复杂化。
- 常研究的生物标志物包括伴放线聚集杆菌(Aggregatibacter actinomycetemcomitans)JP2基因型、牙龈卟啉单胞菌(Porphyromonas gingivalis)、福赛坦氏菌(Tannerella forsythia)和齿垢密螺旋体(Treponema denticola)。
- 最高诊断准确性(AUC > 0.95)通过基于复合微生物组的指标如龈下微生物失调指数实现。
- 方法学异质性和不一致的标准限制了可靠性。
关键数值与推荐
- 纳入标准要求每组至少20名参与者。
- 诊断准确性评估采用敏感性、特异性或AUC,或提供可计算数据。
- 最高诊断准确性为AUC > 0.95,见于龈下微生物失调指数等复合微生物组指标。
临床怎么用
- 原文未据此给出推荐。
局限性
- 采样部位、微生物学分析和诊断定义存在显著变异性,使直接比较复杂化。
- 方法学异质性和不一致的标准限制了可靠性。
- 当前证据不足以用于临床实施。
- 未来研究应标准化方法、采样方案和诊断标准以确保稳健验证并促进整合到精准牙科中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To examine the accuracy of microbiological biomarkers in diagnosing periodontal diseases, specifically addressing three focus questions: (FQ1) distinguishing health from disease; (FQ2) predicting disease progression; and (FQ3) assessing treatment outcomes. MATERIALS AND METHODS: A PRISMA-guided search in MEDLINE, EMBAS and WEB OF SCIENCE included cross-sectional and longitudinal studies (e.g., randomised controlled trials, cohort studies) with ≥ 20 participants per group. Eligible studies involved individuals diagnosed with periodontal health, gingivitis or periodontitis, based on well-defined clinical criteria, and utilised microbiological analyses of oral fluids and/or dental plaque. Diagnostic accuracy had to be evaluated using sensitivity, specificity or area under the receiver operating characteristic (ROC) curve (AUC), or alternatively, data for their computation had to be provided. RESULTS: Thirty-one studies were included, mostly cross-sectional or case-control, with significant variability in sampling sites, microbial analyses and diagnostic definitions, complicating direct comparisons. Frequently investigated biomarkers included Aggregatibacter actinomycetemcomitans (JP2 genotype), Porphyromonas gingivalis , Tannerella forsythia and Treponema denticola . The highest diagnostic accuracy (AUC > 0.95) was achieved through composite microbiome-based metrics such as the subgingival microbial dysbiosis index. However, methodological heterogeneity and inconsistent criteria limited reliability. CONCLUSION: Although microbiological biomarkers hold promise for periodontal disease diagnostics and monitoring, current evidence is insufficient for clinical implementation. Future research should standardise methodologies, sampling protocols and diagnostic criteria to ensure robust validation and facilitate integration into precision dentistry.
引用
- Bostanci N, Manoil D, Van Holm W, et al. Microbial Markers for Diagnosis and Risk Assessment for Periodontal Diseases: A Systematic Literature Search and Narrative Synthesis. J Clin Periodontol. 2025. PMID: 40414257. doi:10.1111/jcpe.14183
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。